Keros Therapeutics Competitors and Similar CompaniesClear all

Keros Therapeutics's competitors and similar companies include Capricor Therapeutics, Regulus Therapeutics, Astellas Gene Therapies and Bath ASU.
Keros Therapeutics
Keros Therapeutics
Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.
Capricor Therapeutics
Capricor Therapeutics
Capricor Therapeutics is a biotechnology company focused on the discovery, development & commercialization of first-in-class therapeutics for the treatment of diseases.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Astellas Gene Therapies
Astellas Gene Therapies
Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Bath ASU
Bath ASU
Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.
Founding Date
Founding Date
2015
Founding Date
2005
Founding Date
2007
Founding Date
2013
Founding Date
2006
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Lexington, US HQ
Locations
Beverly Hills, US HQ
Locations
San Diego, US HQ
Locations
San Francisco, US HQ
Locations
Corsham, GB HQ
Employees
Employees
23
Employees
1854% decrease
Employees
2462% decrease
Employees
20736% increase
Employees
975% increase
Valuation ($)
Valuation ($)
909 m
Valuation ($)
91.1 m
Valuation ($)
26.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
7
Twitter followers
790
Twitter followers
2.7 k
Twitter followers
240
Employee Rating
Employee Rating
2
Employee Rating
2.1
Employee Rating
2.8
Employee Rating
3.2
Employee Rating
2.7

Financial

Net income
Net income
($104.7m) (FY, 2022)
Net income
($29m) (FY, 2022)
Net income
($28.3m) (FY, 2022)
Net income
($128.8m) (FY, 2018)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 90m
Total funding raised
$ 78.5m
Total funding raised
$ 10m
Total funding raised
$ 180m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Capricor Therapeutics
HQ
Beverly Hills, US
Employees
18

Capricor Therapeutics is a biotechnology company focused on the discovery, development & commercialization of first-in-class therapeutics for the treatment of diseases.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Astellas Gene Therapies
HQ
San Francisco, US

Astellas Gene Therapies (formerly known as Audentes Therapeutics) is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.

View company
Bath ASU
HQ
Corsham, GB
Employees
97↑ 5% increase

Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.

View company